Philippen L, Schub N, Gunther A, Cario G, et al. Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease. Bone Marrow Transplant 2023 Nov 6. doi: 10.1038/s41409-023-02144.
PMID: 37932418